Utilization ramped up quickly over the year: Q1 2024: $89.8M reimbursed Q2 2024: $88.5M Q3 2024: $111.5M (highest) Q4 2024: $93.2M Notably, Q3 2024 saw over 108,000 claims for Ozempic 0.25mg alone , signaling both accelerating demand and rising per-unit costs
ANZCA.edu.au
There has also been recent research highlighting the safe and effective use of these therapies in type 1 diabetes, especially in combination with automated insulin delivery (AID)
Key Takeaways There are multiple semaglutide alternatives, including other GLP-1 medications, non-GLP-1 prescriptions, supplements, and lifestyle-based approaches, that can help drive weight loss and other metabolic benefits
Dabigatran etexilate is a prodrug that is converted to its active form by blood esterases
Resignation of top Biden scientific advisor is just another example of the toxic workplace culture plaguing academia, activists say A biotech millionaire claimed his wild routine cut his biological age by 5 years